Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours Β· Estimated delivery Aug 15 - Aug 20
doi:10.1111/j.1462-2920.2005.00966.x
A.SardinhaL
placebo on coronary atherosclerosis progression is currently being measured by multidetector computed tomography angiography over 1 year in ~140 patients with T2D and CVD or at least one CV risk factor in the Semaglutide Treatment On Coronary Progression (STOP
Compliance Statement This product is intended for laboratory research use only and is not approved for human or veterinary use
US$ 23.27
US$ 28.23
US$ 28.78
US$ 27.99
US$ 22.05
